Introduction
Cigarette smoking and second hand smoking (SHS), well-known risk factors, are associated with atherosclerosis (AS), coronary heart disease (CHD), stroke, myocardial infarction, aortic aneurysm, peripheral vascular disease and other cardiovascular diseases [1] .
Smoking per se has been reported to result in 5 million premature deaths per year worldwide, quite interestingly the majority of these are due to a cardiovascular event [2] . It is considered that smoking particles cause damage to the arterial wall with localized dysfunction of the endothelium and enhanced plaque formation [3] . However, the molecular mechanisms involved in this phenomenon are still largely unknown.
Lipid soluble smoking particles (DSP) cause damage to vascular endothelial cells (VECs) and vascular smooth muscle cells (VSMCs) [4] ; reduce the formation and release of prostacyclin from VEC [5, 6] , increase 125 I-low density lipoprotein (LDL) uptake by VSMC; and together with LDL DSP increase the release of growth factors and endothelin-1 (ET-1) [7] . Furthermore, DSP may have a direct toxic effect on VEC and reduce endotheliumdependent dilatation in rat mesenteric arteries and human middle cerebral arteries [8] . As one putative mechanism, DSP result in up-regulation of endothelin A and B (ET A and ET B ) receptors in rat bronchi via a translational mechanism [9] .
Thromboxane (Tx) is widely known as a key inflammatory substance, and mediates VSMC contraction and proliferation via the thromboxane A 2 (TP) receptor [10, 11] . Tx is involved in blood platelet function and linked with hemostasis and thrombosis [12, 13] . The TP receptors density has been reported to be enhanced in cardiovascular disease [14] and in hypertension [15] . Previous experimental and clinical data have demonstrated that treatment with a TP receptor antagonist (e.g. Z-335, BM-573, Ramatroban (Bay U 3405), S18886) provideds positive effects as shown both in vitro and in vivo [16] [17] [18] [19] [20] . Furthermore, injuryinduced vascular proliferation and platelet activation are depressed in mice genetically deficient in the TP receptor or treated with a TP antagonist [21] .
The present study was designed to examine if DSP up-regulates TP receptors in VSMC and molecular mechanisms bind this event. We show for the first time that DPS result in upregulation of TP receptors in rat mesenteric artery SMC via a translational mechanism, while mitogen-activated protein kinase (MAPK) pathways are not involve.
Materials and Methods

Tissue preparation and organ culture procedure
Sprague-Dawley rats (body weight 300-350g) were anaesthetized with CO 2 and exsanguinated. The superior mesenteric artery was gently removed, immersed into cold buffer solution (for composition, see below) and freed of adhering tissue under a dissection microscope. The endothelium was denuded by perfusion of the vessel for 10 seconds with 0.1% Triton X-100 followed by another 10 seconds with a physiologic buffer solution [22] .
The removal of the endothelium was verified by no dilatory response to acetylcholine (10 -6 M)
on 5-hydroxytriptamine (10 -5 M) pre-contracted segments, and confirmed by immunohistology.
The vessels were then cut into 1 mm long cylindrical segments, incubated at 37 °C in humified 5 % CO 2 in air. Culture was carried out in a 24-well plate, two segments in each well, containing 1 ml Dulbecco's modified Eagle's medium (DMEM) containing L-glutamine (584 mg/L) and supplemented with penicillin (100 U/mL) and streptomycin (100 µg/mL) [23] . The experiments were performed in organ culture of the arterial segments with DSP or dimethyl sulphoxide (DMSO). The experimental protocol was approved by Lund University Animal Ethic's Committee (M217-03).
Buffer solutions
Standard buffer solution (mM): NaCl 119; NaHCO 3 15; KCl 4.6; MgCl 1.2; NaH 2 PO 4
1.2; CaCl 2 1.5; glucose 5.5. Analytical grade chemicals and double distilled water were used for preparing all solutions. DMEM, penicillin and streptomycin were purchased from Gibco BRL (Paisley, Scotland).
In vitro pharmacology
Arterial segments were immersed in temperature-controlled (37 °C) myographs (Organ Bath Model 700MO, J.P. Trading, Aarhus, Denmark) containing 5 ml bicarbonate buffer solution. The solution was continuously aerated with 5% CO 2 in O 2 resulting in a pH of 7.4.
The arterial segments were mounted for continuous recording of isometric tension by the Chart software (ADInstruments, Hastings, UK). A resting tone of 2.5 mN was applied to each segment and the segments were allowed to stabilize at this tension for at least 1.5 hrs before being exposed to a potassium-rich (60 mM K + ) buffer solution with the same composition as the standard solution except that NaCl was replaced by an equimolar concentration of KCl.
The potassium-induced contraction was used as a reference for the contractile capacity, and the segments were used only if potassium elicited reproducible responses over 1.0 mN.
Concentration-response curves for vasoconstrictors were obtained by cumulative administration of the reagents [23] .
Intracellular signal inhibitions and drugs
To link intracellular events to functional changes, a set of inhibitors were administered with DSP during organ culture. The MAPK pathway consists of three major members: c-Jun-NH 2 -terminal kinase (JNK), extracellular signal-regulated kinase 1 and 2 (ERK1/2) and p38 [24] . Their specific inhibitors including: SP600125 (10 -5 M, inhibitor of JNK) [25] 
Extraction of DSP
DSP were extracted as previously described [8] . Briefly, three cigarettes (Marlboro, 0.8 mg nicotine per cigarette) were "smoked" by a water aspirator and the smoke was directed through a cotton wool filter. The retained smoke particles in the filter were dissolved in 1 ml DMSO and finally diluted by DMSO to standard nicotine content of 0.1 mg/L [9] .
Data analysis
All data are expressed as mean ± SEM. The amount of receptor mRNA are expressed as percentage of housekeeping gene mRNA, or percentage of control group. Unpaired Student's t-test was used to compare two sets of data and one-way analysis of variance (ANOVA) or two-way ANOVA with Bonferroni post-test for comparisons of more than two data sets. A P value less than 0.05 was considered to be significant.
Results
In vitro pharmacology
The Fig 1A) . However, a higher DSP concentration (0.2 µl/ml) resulted in markedly elevated contractions compared with the DMSO control group (Fig 1B) .
Removal of the endothelium did not affect the contractile responses to U46619 in both The contractile responses to U46619 were shifted towards right by 10 -8 M of the selective TP receptor antagonist, GR32191b, suggesting that U46619-induced contraction is mediated by TP receptor (data not shown).
Nicotine is an important substance in DSP. After organ culture for 24 hrs of the segments, the presence of nicotine (0.02 µg/ml, equivalent amount contained in DSP 0.2 µl/ml) did not result in any altered TP receptor-mediated contractile responses (Fig 1C) .
Receptor mRNA expression and mRNA stability TP receptor mRNA expression in VSMC was detected by real-time RT-PCR. After coculture with DSP 0.2 µl/ml for 24 hrs it was not increased (Fig 2A, P > 0.05) . In mRNA stability tests AcD was added to both DMSO and DSP groups to inhibit de novo synthesis of receptor mRNA for different time points of organ culture. The mRNA appeared to be quite stable in both groups. In parallel with the non-inhibited situation, DSP tended to stabilize mRNA and resulted in a slightly higher mRNA expression after 6 hrs though not significant
Immunohistochemistry
The TP receptor protein was visualized by the fluorescent immuohistology method and analysed by confocal microscopy with the Image J software. Collagen bands (elastic fibres) appeared as orange autofluorescence and the TP-receptor proteins were stained clearly in green colour between the collagen bands. There was only a weak TP receptor protein expression in the DMSO group, localized among the smooth muscle cells ( Figure 3A) .
However, the TP receptor protein was strongly enhanced in the DSP treated group as shown by the bright green granules localized on the SMC ( Figure 3B ). Semi-quantitative measurement of TP receptor protein density showed that DSP significantly enhanced TP receptor protein expression by 2 fold (n = 6, P < 0.001), compared with the control (DMSO) group ( Figure 3C ).
Inhibitor studies
The general transcriptional inhibitor AcD did not affect the elevated TP receptormediated responses elicited by DSP. However, the translational inhibitor CHX almost completely abolished the DSP-induced up-regulation of TP receptors. DEX, a glucocorticoid which shows extensive anti-inflammation effects, attenuated the up-regulation of TP receptor significantly (Fig 4A) . Inhibition experiments of several intracellular pathways were carried out by using a set of specific inhibitors of various MAPK subtypes: JNK (SP600125), ERK1/2 (PD98059 and U0126) and p38 (SB203580). However none of these presented a significant effect (Fig 4B) . Thus, a post-transcriptional mechanism is involved in the DSPinduced up-regulation of TP receptor expression.
Discussion
It is known that Tx and TxA 2 receptors are involved in the atherosclerotic process;
enhanced contraction and proliferation of various cell types involved in the plaque formation [30] . Smoking presents an elevated risk factor enhancing this process. The present study is the In order to examine if the observation that there was no change in TP receptor mRNA was due to an artifact, mRNA stability experiments were carried out. Under the condition that de novo synthesis of receptor mRNA was inhibited, the TP receptor mRNA expression was stable at different time points of the organ culture progress. Despite of the observed nonsignificant differences, DSP showed a tendency to stabilize TP receptor mRNA expression compared with DMSO group. However, the marked increase in receptor protein expression indicates that a translational mechanism is the major cause of TP receptor upregulation. In agreement with the present study, we have previously reported that DSP enhances ET A and ET B receptor expression through a translational mechanism in rat bronchioles [9] . The up-regulation of TP receptors may also occur through inhibition of the receptor protein break down mechanisms. However, CHX is a well-known general translational inhibitor that acts on both the synthesis of TP receptor protein and degrading enzymes for the TP receptors. If the degrading enzymes are inhibited by CHX, it could lead to more TP receptor proteins and enhanced contractile responses to U46619. The present study showed that CHX had an inhibitory effect on the up-regulation of TP receptors. This suggests that CHX specifically acts on the translation process of TP receptors rather than degrading enzymes for TP receptors.
Previous investigations have revealed that TxA 2 generation is increased in aortic segments of cholesterol-fed atherosclerotic rabbits [34] ; and that in two transgenic murine models of atherogenesis the Tx biosynthesis is elevated [35] . In addition, it has been reported that in coronary artery smooth muscle cells, thrombin-induced proliferation is markedly enhanced by TxA 2 and this involves up-regulation of TP receptor mRNA [36] . Thus, there exist data supporting that the TP receptor is an important target in prevention and treatment of atherosclerosis. Antagonists for TP receptors have achieved positive effects in experimental and clinical trials [16] [17] [18] [19] [20] , and antagonism or deletion of TP receptor expression retards atherogenesis in apolipoprotein E knockout mice [37] . In our study, we have described a novel method for studies of the up-regulation of TP receptor expression induced by smoking particles which also suggests a possible role for active or passive cigarette smoking to promote atherogenesis and vascular diseases.
As a member of glucocorticoids family DEX exhibits non-specific anti-inflammation effects through several mechanisms. Firstly, it suppresses gene expression at the transcriptional level via inhibition of transcription factors such as nuclear factor-κB (NF-κB) and activator protein-1 (AP-1) [38, 39] ; secondly, post-transcriptional mechanisms account for the effects of DEX by depressing protein expression, including destabilization and translational inhibition of mRNA [40, 41] . In the present study, the inefficiency of the transcriptional inhibitor AcD as well as the specific MAPK inhibitors indicate that transcription does not account for the up-regulation of TP receptors. Therefore, it is suggested that DEX has effect via a post-transcriptional process rather than a transcriptional mechanism.
Glucocorticoids have been used in the treatment of experimental atherosclerosis [42, 43] and restenosis after coronary artery angioplasty [44] , showing some anti-atherogenic effects. In human aortic smooth muscle cells, DEX may attenuate intimal proliferation at the site of vascular injury during atherogenesis [45] .
In the present setup, DSP was quantified and standardized with nicotine content as an internal quantitative control for the DSP. The DSP preparations were analyzed by gas chromatography and then diluted by DMSO to standard nicotine content (0.1 mg/ml) [8, 9] . It has been reported that in smokers, the plasma concentration of nicotine varies between 4 -72 ng/ml, and that the average concentration is 33 ng/ml [46] . In the present study, we used DSP 0.2 µl/ml which contains 20 ng/ml of nicotine. The used concentration is therefore slightly below the average plasma concentration in smokers, and thus our findings are relevant to in vivo both for active and passive smoking.
Nicotine, one of the key substances in smoking particles, was also examined in the present study. Equivalent amounts of nicotine as occur in DSP did not affect the contractile responses to U46619 after organ culture, suggesting that in our model nicotine is unrelated to the up-regulation of TP receptors. This finding is in concert with a previous study in which nicotine did not contribute to the increased production of TxA 2 following cigarette smoking in man no matter if it was studied in vitro or in vivo [47] . In a smoke exposed guinea pig model, the second-phase response of the bronchoconstriction characterized by the release of TxA 2 , prostaglandin D 2 , and prostaglandin F 2α , which act on TP receptors in airway smooth muscles, was shown to be evoked by non-nicotine smoking particulates [48] .
As a complex, smoking particles consist of more than 4000 different substances. It is difficult to verify which substances are mainly responsible for the up-regulation of TP receptors. Despite that the involvement of nicotine has been excluded here, reports have demonstrated that polycyclic aromatic hydrocarbons (dimethylbenzanthracene and benzpyren) and oxidants like free radicals are contained in DSP. These particles may result in dysfunction of the arterial cells [7, 49, 50] in aspects to cell proliferation, release of vasoactive substances as well as alteration of vascular receptors.
In conclusion, the present study is the first to conclusively demonstrate that smoking particles provoke up-regulation of TP receptors, with increased receptor expression and enhanced contractility in VSMC. This up-regulation occurs through a translational mechanism.
The elevated TP receptor expression may contribute to the development of atherosclerosis and cardiovascular diseases. Each data point is derived from 6 experiments. Two-tailed unpaired Student's t-test with Welch´s correction, *** P < 0.001 compared with control (DMSO). 
